News|Articles|April 10, 2020

IMA Introduces a Digital Platform for Remote FAT

The platform is part of IMA’s remote factory acceptance testing (FAT) initiative that involves providing customers with virtual solutions to meet their machine and packaging testing needs.

IMA Group introduced Stay Connect!, a digital platform that monitors the status of equipment while offering technical assistance, augmented and virtual reality capabilities, and digital documentation applications. The platform is part of IMA’s remote factory acceptance testing (FAT) initiative that involves providing customers with virtual solutions to meet their machine and packaging testing needs. The virtual FAT takes the place of customers coming to IMA’s factory; IMA’s engineers can test the machinery with the customer witnessing all the tests via broadcast streaming.

The design of the platform works to support designers and test machine software in digital environments using virtual commissioning. The platform’s virtual mock-up is formulated to test ergonomics and improve interaction between operators and machines. Additionally, IMA has included augmented reality for remote assistance and a Connected Field Force APP feature to guide partners in step-by-step resolution of problems or malfunctions.

“We are always fully active and in force, despite today’s uncertain environment, to support customers in the management of installed machines and in solving technical problems,” said Massimo Ferioli, director of IMA and coordinator of the IMA Digital initiative, in a company press release. “The products developed as part of the IMA Digital initiative are helping us a lot and allow us to be able to confirm the timelines and deliveries of the machineries and ongoing projects.”

Source: IMA Group

 

 

 


Related to this article

Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation. | Image Credit: ©HockleyMedia24/peopleimages.com -stock.adobe.com
Equivalence test using two one-sided tests are widely used for demonstrating the comparability of treatment effects in different research fields. The method described in the manuscript aims to use simulations in Microsoft Excel to compute power for 2 one-sided tests for two groups with unequal variances.
Complying with International Pharmacopoeias
Susan J. Schniepp, distinguished fellow with Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical, with Parexel, clear up some of the confusion about what does and does not need to be complied with regarding standards set by international pharmacopoeias.
CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 2
Mitigating nitrosamine risk requires assessing each product individually, says Bram Baert, Global Head of Regulatory Affairs at Capsugel, and Sandrine Picco, Senior Analytical Specialist on Capsugel's Innovaform Accelerator Team, in this interview with PharmTech.